MedPath

Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease?

Not Applicable
Conditions
Allergies
Registration Number
NCT00892684
Lead Sponsor
Linkoeping University
Brief Summary

The incidence of allergic diseases has increased and a relation between allergy and dietary fatty acids has been proposed. Modulation of the maternal immune function during pregnancy may have an impact on future clinical outcomes in the child. The aim of this study was to determine the effects of omega (Ο‰) - 3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation during pregnancy and lactation on the development of allergic disease (i.e., allergic eczema) in the child at 2 years of age. Pregnant women with allergic disease in their immediate family were supplemented daily with 2.7 g Ο‰-3 LCPUFA (n=70) or 2.8 g soybean-oil as placebo (n=75) from gestational week (gw) 25 until the third month of breastfeeding. Skin prick tests, detection of circulating specific IgE antibodies and clinical examinations of the infants were performed at 3, 6, 12 and 24 months of age. The mothers and children were monitored regarding immune modulatory effects during the entire study period.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
146
Inclusion Criteria
  • Pregnant woman, at 25 weeks of gestation, with allergic symptoms (rhinitis, conjunctivitis, eczema, asthma or food allergy) herself or the father to be or an older sibling
Exclusion Criteria
  • Soy allergy
  • Fish allergy
  • Treatment with anti-coagulation
  • Commercial omega-3 supplementation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
allergic eczema2 years
Secondary Outcome Measures
NameTimeMethod
changes in laboratory parameters such as prostaglandins and cytokines associated to the intervention and the primary outcome25th gestational week, at partus and 12 months after partus for the mothers, in cord blood at 3, 12 and 24 months for the children

Trial Locations

Locations (1)

University Hospital

πŸ‡ΈπŸ‡ͺ

Linkoeping, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath